Högl B - Search Results

1

Clinical trials in REM sleep behavioural disorder: challenges and opportunities.

Videnovic A, Ju YS, Arnulf I, Cochen-De Cock V, Högl B, Kunz D, Provini F, Ratti PL, Schiess MC, Schenck CH, Trenkwalder C; Treatment and Trials Working Group of the International RBD Study Group. Videnovic A, et al. Among authors: hogl b. J Neurol Neurosurg Psychiatry. 2020 Jul;91(7):740-749. doi: 10.1136/jnnp-2020-322875. Epub 2020 May 13. J Neurol Neurosurg Psychiatry. 2020. PMID: 32404379 Free PMC article. Review.

2

Polysomnographic measures in Parkinson's disease: a comparison between patients with and without REM sleep disturbances.

Wetter TC, Trenkwalder C, Gershanik O, Högl B. Wetter TC, et al. Among authors: hogl b. Wien Klin Wochenschr. 2001 Apr 17;113(7-8):249-53. Wien Klin Wochenschr. 2001. PMID: 11383385

3

[Pathophysiology, clinical aspects and therapy of sleep disorders in Parkinson disease].

Högl B, Wetter TC, Trenkwalder C. Högl B, et al. Nervenarzt. 2001 Jun;72(6):416-24. doi: 10.1007/s001150050773. Nervenarzt. 2001. PMID: 11433700 Review. German.

4

Effect of sleep deprivation on motor performance in patients with Parkinson's disease.

Högl B, Peralta C, Wetter TC, Gershanik O, Trenkwalder C. Högl B, et al. Mov Disord. 2001 Jul;16(4):616-21. doi: 10.1002/mds.1138. Mov Disord. 2001. PMID: 11481684 Clinical Trial.

5

Increased alpha activity in REM sleep in de novo patients with Parkinson's disease.

Wetter TC, Brunner H, Högl B, Yassouridis A, Trenkwalder C, Friess E. Wetter TC, et al. Among authors: hogl b. Mov Disord. 2001 Sep;16(5):928-33. doi: 10.1002/mds.1163. Mov Disord. 2001. PMID: 11746625

6

Microstructure of the non-rapid eye movement sleep electroencephalogram in patients with newly diagnosed Parkinson's disease: effects of dopaminergic treatment.

Brunner H, Wetter TC, Hogl B, Yassouridis A, Trenkwalder C, Friess E. Brunner H, et al. Among authors: hogl b. Mov Disord. 2002 Sep;17(5):928-33. doi: 10.1002/mds.10242. Mov Disord. 2002. PMID: 12360541

7

The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease.

Chaudhuri KR, Pal S, DiMarco A, Whately-Smith C, Bridgman K, Mathew R, Pezzela FR, Forbes A, Högl B, Trenkwalder C. Chaudhuri KR, et al. Among authors: hogl b. J Neurol Neurosurg Psychiatry. 2002 Dec;73(6):629-35. doi: 10.1136/jnnp.73.6.629. J Neurol Neurosurg Psychiatry. 2002. PMID: 12438461 Free PMC article.

8

The effect of cabergoline on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson's disease.

Högl B, Rothdach A, Wetter TC, Trenkwalder C. Högl B, et al. Neuropsychopharmacology. 2003 Oct;28(10):1866-70. doi: 10.1038/sj.npp.1300250. Neuropsychopharmacology. 2003. PMID: 12865895 Clinical Trial.

9

Restless legs syndrome: diagnostic assessment and the advantages and risks of dopaminergic treatment.

Högl B, Paulus W, Clarenbach P, Trenkwalder C. Högl B, et al. J Neurol. 2006 Aug;253 Suppl 4:IV22-8. doi: 10.1007/s00415-006-4005-3. J Neurol. 2006. PMID: 16944353

10

Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: results from a multi-center, randomized, active controlled trial.

Trenkwalder C, Benes H, Grote L, Happe S, Högl B, Mathis J, Saletu-Zyhlarz GM, Kohnen R; CALDIR Study Group. Trenkwalder C, et al. Among authors: hogl b. Mov Disord. 2007 Apr 15;22(5):696-703. doi: 10.1002/mds.21401. Mov Disord. 2007. PMID: 17274039 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

339 results

Search Page